<?xml version="1.0" encoding="UTF-8"?>
<compound>
  <id type="integer">347907</id>
  <title nil="true"/>
  <common-name>2-[[1-[[4-(4-methylphenyl)piperazin-1-yl]methyl]benzimidazol-2-yl]methyl]-5-nitroisoindole-1,3-dione</common-name>
  <description>2-[[1-[[4-(4-methylphenyl)piperazin-1-yl]methyl]benzimidazol-2-yl]methyl]-5-nitroisoindole-1,3-dione is a chemical compound with the formula C28H26N6O4. With an average molecular weight of 510.50 g/mol, 2-[[1-[[4-(4-methylphenyl)piperazin-1-yl]methyl]benzimidazol-2-yl]methyl]-5-nitroisoindole-1,3-dione is a heavy molecule.</description>
  <cas>115398-88-4</cas>
  <pubchem-id>3087648</pubchem-id>
  <chemical-formula>C28H26N6O4</chemical-formula>
  <weight>510.5</weight>
  <appearance nil="true"/>
  <melting-point nil="true"/>
  <boiling-point nil="true"/>
  <density nil="true"/>
  <solubility nil="true"/>
  <specific-gravity nil="true"/>
  <flash-point nil="true"/>
  <vapour-pressure nil="true"/>
  <route-of-exposure nil="true"/>
  <target nil="true"/>
  <mechanism-of-toxicity nil="true"/>
  <metabolism nil="true"/>
  <toxicity nil="true"/>
  <lethaldose nil="true"/>
  <carcinogenicity nil="true"/>
  <use-source nil="true"/>
  <min-risk-level nil="true"/>
  <health-effects nil="true"/>
  <symptoms nil="true"/>
  <treatment nil="true"/>
  <created-at type="dateTime">2026-08-31T11:45:35Z</created-at>
  <updated-at type="dateTime">2026-08-31T11:45:35Z</updated-at>
  <interacting-proteins nil="true"/>
  <wikipedia nil="true"/>
  <uniprot-id nil="true"/>
  <kegg-compound-id nil="true"/>
  <omim-id nil="true"/>
  <chebi-id nil="true"/>
  <biocyc-id nil="true"/>
  <ctd-id nil="true"/>
  <stitch-id nil="true"/>
  <drugbank-id nil="true"/>
  <pdb-id nil="true"/>
  <actor-id nil="true"/>
  <organism nil="true"/>
  <export type="boolean">true</export>
  <metabolizing-proteins nil="true"/>
  <transporting-proteins nil="true"/>
  <moldb-smiles>CC1=CC=C(C=C1)N2CCN(CC2)CN3C4=CC=CC=C4N=C3CN5C(=O)C6=C(C5=O)C=C(C=C6)[N+](=O)[O-]</moldb-smiles>
  <moldb-formula>C28H26N6O4</moldb-formula>
  <moldb-inchi>InChI=1S/C28H26N6O4/c1-19-6-8-20(9-7-19)31-14-12-30(13-15-31)18-33-25-5-3-2-4-24(25)29-26(33)17-32-27(35)22-11-10-21(34(37)38)16-23(22)28(32)36/h2-11,16H,12-15,17-18H2,1H3</moldb-inchi>
  <moldb-inchikey>PTHOBLXWJGJARJ-UHFFFAOYSA-N</moldb-inchikey>
  <moldb-average-mass type="decimal" nil="true"/>
  <moldb-mono-mass type="decimal">510.2015533</moldb-mono-mass>
  <origin nil="true"/>
  <state nil="true"/>
  <logp>3.8</logp>
  <hmdb-id nil="true"/>
  <chembl-id nil="true"/>
  <chemspider-id nil="true"/>
  <structure-image-file-name nil="true"/>
  <structure-image-content-type nil="true"/>
  <structure-image-file-size type="integer" nil="true"/>
  <structure-image-updated-at type="dateTime" nil="true"/>
  <biodb-id nil="true"/>
  <synthesis-reference nil="true"/>
  <structure-image-caption nil="true"/>
  <chemdb-id>CHEM343800</chemdb-id>
  <dsstox-id nil="true"/>
  <toxcast-id nil="true"/>
  <stoff-ident-origin nil="true"/>
  <stoff-ident-id nil="true"/>
  <susdat-id nil="true"/>
  <iupac>2-[[1-[[4-(4-methylphenyl)piperazin-1-yl]methyl]benzimidazol-2-yl]methyl]-5-nitroisoindole-1,3-dione</iupac>
  <moldb-polar-surface-area nil="true"/>
  <moldb-refractivity nil="true"/>
  <moldb-polarizability nil="true"/>
  <moldb-rotatable-bond-count nil="true"/>
  <moldb-acceptor-count nil="true"/>
  <moldb-donor-count nil="true"/>
  <moldb-pka-strongest-acidic nil="true"/>
  <moldb-pka-strongest-basic nil="true"/>
  <moldb-physiological-charge nil="true"/>
  <moldb-number-of-rings nil="true"/>
  <moldb-alogps-logp nil="true"/>
  <moldb-alogps-logs nil="true"/>
  <moldb-alogps-solubility nil="true"/>
  <kingdom>Organic compounds</kingdom>
  <superklass>Organoheterocyclic compounds</superklass>
  <klass>Diazinanes</klass>
  <subklass>Piperazines</subklass>
  <paper-count type="integer" nil="true"/>
  <sync-id>CED0298243</sync-id>
  <structure-inchikey>PTHOBLXWJGJARJ-UHFFFAOYSA-N</structure-inchikey>
  <structure-fingerprint>80000000400000020800000000000000000008000000000000000005000000000000040000022002000008400002000000100000000000000000000000000100000000000000000080000000000002020000000810000001000000000400000000000200000000200000000110000000000020100000000000000000000000100000040008000804000000000000000000000001100000000000000000020040000000000000000000000080000040000000000000000008000000800001000000000000000000000000000000000001000000000002001800200040000010000420140000001000040000000008080000800001000000000000000000000</structure-fingerprint>
  <structure-pattern-fingerprint>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</structure-pattern-fingerprint>
  <structure-pickle type="binary" encoding="base64">776t3gAAAAAQAAAAAwAAAAAAAAAmAAAAKwAAAIABBgBgAAAAAQMGQCgAAAAD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</structure-pickle>
  <structure-indexed-at type="dateTime">2026-09-19T05:46:27Z</structure-indexed-at>
</compound>
